Mercado global de perturbação de stress pós-traumático (PTSD) – Tendências do setor e previsão para 2030

Análise e dimensão do mercado de perturbação de stress pós-traumático (PTSD)

O mercado global de PTSD tem registado um crescimento constante e espera-se que continue a expandir-se. A crescente prevalência do TEPT, juntamente com as crescentes taxas de sensibilização e diagnóstico, estão a impulsionar o crescimento do mercado. Fatores como o aumento de eventos traumáticos, destacamentos militares, desastres naturais e ataques terroristas contribuem para a procura de tratamentos de PTSD.

A Data Bridge Market Research analisa que o mercado global de perturbação de stress pós-traumático (PTSD), que foi de 750,30 milhões de dólares em 2022, dispararia para 1.037,95 milhões de dólares até 2030, e deverá passar por um CAGR de 4,1% durante o período de previsão. Os “antidepressivos” dominam o segmento de produtos do mercado global (PTSD) devido ao crescente investimento na saúde. Para além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem análise especializada aprofundada, epidemiologia do paciente, análise de pipeline, análise de preços e quadro regulamentar.

Âmbito e segmentação do mercado da perturbação de stress pós-traumático (PTSD)

Market Definition

The global PTSD market includes pharmaceuticals, psychotherapeutic interventions, digital health solutions, diagnostic tools, and other supportive services that contribute to the prevention, diagnosis, and treatment of PTSD. The market encompasses various stakeholders such as pharmaceutical companies, mental health service providers, research organizations, government bodies, and advocacy groups working together to address the impact of PTSD and improve the lives of individuals affected by the disorder.

Global Post-Traumatic Stress Disorder (PTSD) Market Dynamics

Drivers

• Rising awareness of PTSD symptoms

There is a growing awareness of mental health issues, including PTSD, among the general public, healthcare professionals, and policymakers. Increased awareness leads to early detection and intervention, creating a higher demand for effective treatments and interventions. Public campaigns, educational initiatives, and media attention help reduce stigma and encourage individuals to seek help for their PTSD symptoms.

• Government Initiatives

Governments and public health organizations worldwide have recognized the significant impact of PTSD on individuals and society. They have implemented initiatives, policies, and funding support to improve PTSD care, promote research, and enhance mental health services. Government initiatives drive market growth by providing resources, raising awareness, and improving access to PTSD treatments.

Opportunity

• Advancements in personalized medicines

Advancements in genetics and biomarker research offer opportunities for personalized medicine approaches in PTSD management. Identifying genetic and molecular markers associated with PTSD susceptibility and treatment response can help tailor interventions to individual patients. This approach has the potential to improve treatment outcomes and minimize adverse effects by targeting specific biological pathways and optimizing therapy based on patients' unique characteristics.

Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, the rising number of market players will further expand the market's growth rate in the future. 

Restraint/Challenge

• High Cost Associated with The Product Manufacturing

On the other hand, the high cost associated with product manufacturing is expected to obstruct market growth. Also, the disruption in the supply chain industry has the potential to challenge the market’s growth. Also, the lack of favorable reimbursement scenarios and technology penetration in the developing economies, and the lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.

This global post-traumatic stress disorder (PTSD) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global Post-Traumatic Stress Disorder (PTSD) Market, contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In 2021, Tonix Pharmaceuticals received Fast Track designation from the U.S. FDA for its investigational drug TNX-102 SL for the treatment of PTSD
• In 2020, AstraZeneca entered into a collaboration with Vanderbilt University to develop and commercialize compounds targeting the corticotropin-releasing factor 1 (CRF1) receptor for the potential treatment of PTSD and other mental health disorders.

Global Post-Traumatic Stress Disorder (PTSD) Market Scope

The global (PTSD) market is segmented on the basis of product, application, and end users. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Product

• Antidepressants
• Cognitive Therapy
• Anti-Anxiety Drugs
• Exposure Therapy
• Eye Movement Desensitization and Reprocessing (EMDR)
• PSTD therapeutics

Application

• Children
• Adult

End Use

• Hospitals
• Clinics

Global Post-Traumatic Stress Disorder (PTSD) Market   Regional Analysis/Insights

Global post-traumatic stress disorder (PTSD) market is analyzed, and market size insights and trends are provided by product, application, and end use as referenced above.

The countries covered in the global Post-Traumatic Stress Disorder (PTSD) market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.

North America is expected to dominate the market due to rising healthcare costs, increased R & D, and trending technological advancements.

Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising strategic initiatives by the key market players and favorable government initiatives in the region.

A secção do relatório sobre países também fornece fatores individuais que impactam o mercado e alterações na regulamentação do mercado que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas europeias e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado de PTSD também fornece uma análise de mercado detalhada para o crescimento de cada país em gastos de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado, o impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulatórios de saúde e o seu impacto no mercado. Os dados estão disponíveis para o período histórico 2015-2021

Análise do panorama competitivo e da quota de mercado do transtorno de stress pós-traumático (PTSD)

O cenário competitivo do mercado fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, e domínio da aplicação. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado da perturbação de stress pós-traumático (PTSD) são:

• GlaxoSmithKline plc. (REINO UNIDO)
• (EUA)
• Eli Lilly and Company (EUA)
• H. Lundbeck A/S (Dinamarca)
• (EUA)
• (EUA)
• (EUA)
• Bionomia (Austrália)
• Greenstone LLC (EUA)
• Mylan NV(EUA)
• Otsuka Pharmaceutical Co., Ltd (Japão)
• Prometheon Pharma, LLC. (NÓS)
• Ligand Pharmaceuticals Incorporated (EUA)
• Lycera (EUA)
• JSC Valenta Pharm. (Rússia)
• (Canadá)
• Zhenxiang Electromechanical Technology (Shanghai) Co., Ltd.
• AstraZeneca (Reino Unido)
• (EUA)

SKU-57481